SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel's stock is trending following its latest earnings report, where strong Q4 results were overshadowed by weaker-than-expected Q1 guidance and acknowledged production bottlenecks. The community is sharply divided, with bears pointing to overvaluation and manufacturing challenges, while bulls emphasize Intel's strategic national security importance and long-term turnaround potential amid government backing.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is experiencing significant upward momentum, largely driven by rival Intel's recent disappointing earnings report and weak forward guidance, which the community interprets as a clear sign of AMD gaining market share. Traders are actively discussing the implications of Intel's struggles, with many anticipating new all-time highs for AMD amid strong underlying demand for high-performance chips and AI accelerators.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is seeing heightened interest driven by its Breakthrough Therapy Designation for pemvidutide, signaling strong potential in the competitive obesity and liver disease market. The community is actively discussing the drug's differentiated profile, including muscle-sparing weight loss, fueling speculation about an impending partnership or acquisition by a major pharmaceutical player. This robust sentiment is further amplified by its current valuation and notable short interest, pointing to a potential for significant price movements.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as news breaks of China approving H200 chip orders, fueling speculation about accelerating demand for its next-gen Rubin architecture and solidifying its role in global AI infrastructure. The community is actively debating its market performance, with many highlighting its expanding reach into diverse sectors like AI PCs and sovereign AI factories, especially in contrast to competitors' recent struggles.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics ($SNSE) is trending with intense community discussion centered on its extremely low share float and the potential for a massive short squeeze. While skepticism regarding the company's operational status and "pump and dump" claims is present, many anticipate a significant price surge, fueled by its strategic review and cash position as catalysts for a potential corporate event.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano Inc. is trending following news that its merger partner, Corvex, secured a long-term NVIDIA H200 GPU deployment to support AI workloads. The community is actively discussing the stock's low float and its connection to the booming AI sector, driving conversation around significant upside potential while some also express skepticism about the news as a potential pump and dump.

RYVYL Inc. is a financial technology company that develops software platforms and tools that are focused on providing global payment acceptance and disbursement capabilities. It offers an innovative payment platform-as-a-service that redefines global payment solutions, enabling seamless business-to-business, consumer-to-business, and peer-to-peer transactions worldwide. The company leverages advanced electronic payment technology to deliver seamless financial solutions across global markets. It operates through two geographical segments: North America and International. The company was founded on April 10, 2007 and is headquartered in San Diego, CA.

Ryvyl Inc

Ryvyl Inc. is experiencing significant trading activity driven by its extremely low public float and high volume, sparking community discussions around a potential short squeeze. Recent filings for its merger with Roundtable, including a significant strategic partnership with The Hockey News, are fueling speculation about its future as a Web3 digital media and fintech platform. The company's ongoing efforts to maintain NASDAQ compliance are also a key focus among investors.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as the community debates the implications of its TikTok deal, with many anticipating a significant price surge and short squeeze on news of its finalization. While some see the recent dip as a prime buying opportunity, betting on its AI infrastructure and cloud potential, others remain cautious, citing debt concerns and potential "sell the news" volatility.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network (BNAI) is seeing significant attention after finalizing a strategic AI licensing partnership in Africa, including a pilot program with Nelson Mandela University. Traders are actively discussing the stock's potential for a short squeeze, citing its thin float, high short interest, and elevated borrow fees as factors amplifying current momentum within the AI microcap sector.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is actively discussed as its Q2 earnings report on February 3rd approaches, notably without a preceding business update. This has fueled community speculation that the company is poised to meet or exceed revenue and EPS expectations, driving strong calls for a short squeeze given its perceived undervaluation in the crucial AI infrastructure sector. Despite ongoing discussions around gross margins, many view SMCI as a pivotal player poised for significant movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gossamer Bio (NASDAQ:GOSS) Given Buy Rating at HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $10.00 price target on shares of Gossamer Bio in a research note on Thursday...

Gossamer Bio (NASDAQ:GOSS) Trading Down 4.7% - Time to Sell?

Gossamer Bio (NASDAQ:GOSS) Trading Down 4.7% - Here's What Happened...

Gossamer Bio, Inc. (NASDAQ:GOSS) Given Average Recommendation of "Moderate Buy" by Analysts

Gossamer Bio, Inc. (NASDAQ:GOSS - Get Free Report) has received an average rating of "Moderate Buy" from the six brokerages that are covering the firm, MarketBeat.com reports. One equities research...

Gossamer Bio (NASDAQ:GOSS) Shares Down 6.8% - What's Next?

Gossamer Bio (NASDAQ:GOSS) Trading Down 6.8% - What's Next...

Gossamer Bio (NASDAQ:GOSS) Stock Price Down 3.6% - What's Next?

Gossamer Bio (NASDAQ:GOSS) Trading Down 3.6% - Time to Sell...

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...

Gossamer Bio (NASDAQ:GOSS) Stock Price Down 4.1% - Should You Sell?

Gossamer Bio (NASDAQ:GOSS) Trading Down 4.1% - Here's Why...

Gossamer Bio (NASDAQ:GOSS) Shares Up 9.2% - Here's Why

Gossamer Bio (NASDAQ:GOSS) Shares Up 9.2% - What's Next...

Corient Private Wealth LLC Purchases 302,200 Shares of Gossamer Bio, Inc. $GOSS

Corient Private Wealth LLC grew its holdings in Gossamer Bio, Inc. (NASDAQ:GOSS - Free Report) by 8.9% during the second quarter, according to its most recent disclosure with the Securities...

Gossamer Bio, Inc. (NASDAQ:GOSS) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Gossamer Bio, Inc. (NASDAQ:GOSS - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the company, Marketbeat reports...

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.

Gossamer Bio Inc

Policy uncertainty from Trump

Earnings & guidance

Options / dealer positioning

Liquidity & algos

Markets are reacting to a mix of policy headlines, earnings, and positioning. We want to hear what you think is driving volatility the most right now.

What&#39;s the biggest driver of market volatility right now?

Stocktwits

What's the biggest driver of market volatility right now?

GOSS
Gossamer Bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GOSS News

GOSSGossamer Bio Inc